Violation Tracker Parent Company Summary
|Top 5 Offense Groups (Groups Defined)||Penalty Total||Number of Records|
|Top 5 Primary Offense Types||Penalty Total||Number of Records|
|off-label or unapproved promotion of medical products||$34,000,000||2|
|False Claims Act and related||$25,350,000||3|
|benefit plan administrator violation||$5,500,000||1|
|price-fixing or anti-competitive practices||$2,275,454||1|
|workplace safety or health violation||$6,750||1|
Parent-subsidiary linkages are based on relationships current as of the latest revision listed in the Update Log, which may vary from what was the case when a violation occurred. The penalty totals are adjusted to account for the fact that the individual entries below may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. The totals are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the list below.
Schwarz Pharma Inc.; SCHWARZ PHARMA MFG; UCB; UCB Holdings, Inc.; UCB Pharma, Inc.
Subsidy Tracker data on financial assistance to this company by federal, state and local government agencies can be found here.
Individual Penalty Records:Click on the company or penalty amount for more information on each case.
|Company||Primary Offense Type||Year||Agency||Penalty Amount|
|Schwarz Pharma Inc.||False Claims Act and related||2010||DOJ_CIVIL||$22,000,000|
|Schwarz Pharma Inc.||False Claims Act and related||2010||MULTI-AG||(*) $9,756,164|
|SCHWARZ PHARMA MANUFACTURING, INC.||workplace safety or health violation||2010||OSHA||$6,750|
|UCB||False Claims Act and related||2013||LA-AG||$3,350,000|
|UCB Holdings, Inc.||benefit plan administrator violation||2017||private lawsuit-federal||$5,500,000|
|UCB Inc.||off-label or unapproved promotion of medical products||2011||FDA||$34,000,000|
|UCB Inc.||off-label or unapproved promotion of medical products||2011||MULTI-AG||(*) $9,893,322|
|UCB Pharma, Inc.||price-fixing or anti-competitive practices||2009||MULTI-AG||$2,275,454|